KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,720
0.00 (0.00%)
At close: Feb 13, 2026

KOREA PHARMA Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
138,733166,982257,943233,403529,520242,129
Market Cap Growth
-18.62%-35.26%10.51%-55.92%118.69%-
Enterprise Value
143,543151,067248,815222,946528,191235,248
Last Close Price
12720.0015251.2123482.1421200.5747987.2421920.01
PE Ratio
796.6144.043079.40-83.1576.65
Forward PE
-82.1082.1082.10112.1339.78
PS Ratio
1.542.053.102.886.653.39
PB Ratio
1.952.343.763.909.215.21
P/TBV Ratio
2.062.483.964.109.725.50
P/FCF Ratio
-34.8178.4440.14114.12-
P/OCF Ratio
26.3420.7553.5228.1973.62-
EV/Sales Ratio
1.591.862.992.756.643.29
EV/EBITDA Ratio
17.9417.0128.7526.0271.4634.47
EV/EBIT Ratio
29.2924.8242.6036.03105.3451.10
EV/FCF Ratio
-8.7031.4975.6738.34113.83-
Debt / Equity Ratio
0.540.320.510.910.940.30
Debt / EBITDA Ratio
5.932.584.036.387.272.04
Debt / FCF Ratio
-4.7710.609.4011.58-
Net Debt / Equity Ratio
0.07-0.21-0.20-0.14-0.15-0.11
Net Debt / EBITDA Ratio
0.75-1.66-1.55-0.99-1.19-0.72
Net Debt / FCF Ratio
-0.29-3.08-4.09-1.45-1.901.73
Asset Turnover
0.750.700.660.620.760.97
Inventory Turnover
2.592.462.592.672.402.30
Quick Ratio
1.172.761.891.143.131.13
Current Ratio
1.703.812.561.413.811.79
Return on Equity (ROE)
0.24%5.42%0.13%-1.91%12.25%8.64%
Return on Assets (ROA)
1.74%3.26%2.89%2.97%2.97%3.89%
Return on Invested Capital (ROIC)
4.34%10.57%0.46%12.37%11.11%10.32%
Return on Capital Employed (ROCE)
3.80%6.50%6.60%10.10%4.80%9.10%
Earnings Yield
0.13%2.27%0.03%-0.48%1.20%1.31%
FCF Yield
-11.89%2.87%1.27%2.49%0.88%-1.18%
Payout Ratio
313.13%14.38%651.04%-8.56%13.91%
Buyback Yield / Dilution
-15.73%-15.33%3.63%1.22%-12.80%-10.95%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.